Earnings Feed
Start Free
|3Jan 9, 9:27 PM ET

E&Investment, Inc. 3

3 · NeuroBo Pharmaceuticals, Inc. · Filed Jan 9, 2020

Insider Transaction Report

Form 3
Period: 2019-12-30
NeuroBo Pharmaceuticals, Inc.NRBO
E&Investment, Inc.
10% Owner
Holdings

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund II)
    4,335,800

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 7)
    1,864,799

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 6)
    1,121,190
Footnotes (4)
  • [F1]These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund II.
  • [F2]These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No. 6
  • [F3]These shares are owned directly by The E&Healthcare Investment Fund No.7, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No.7.
  • [F4]E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Documents

2 files